Regulus Therapeutics (RGLS) Fails to deliver data

Key failure to deliver metrics for Regulus Therapeutics:

• Last SEC data release: 2025-01-31
• Last 15 days FTD volume: €0.02 M
• Last 3 months FTD volume: €0.29 M
• Last year FTD volume: €0.29 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Regulus Therapeutics (RGLS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Regulus Therapeutics (RGLS) - since 2022

Regulus Therapeutics (RGLS) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
GlaxoSmithKline GSK	€94.71 M	€0.14 B	🇬🇧 UK
Sanofi SNY	€1.53 M	€65.43 M	🇫🇷 France
Biogen BIIB	€36.5 M	€84.81 M	🇺🇸 USA
AstraZeneca AZN	€54.5 M	€0.18 B	🇬🇧 UK
Alnylam Pharmaceuticals ALNY	€12.48 M	€36.02 M	🇺🇸 USA
Sangamo Therapeutics SGMO	€2.42 M	€6.32 M	🇺🇸 USA
Bristol-Myers Squibb BMY	€0.17 B	€0.47 B	🇺🇸 USA